Indeed, the reduction in CD206 staining evident in MMTV-Neu tumors treated with V-125 (Fig. 5) confirms that this compound reduces populations of immunosuppressive macrophages associated with tumor progression. This evidence concerns the gene ERBB2 and neoplasm.